Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$300.63 - $371.35 $1.55 Million - $1.92 Million
-5,170 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$310.19 - $376.2 $1.6 Million - $1.94 Million
5,170 New
5,170 $1.68 Million
Q1 2021

May 17, 2021

SELL
$285.92 - $355.13 $20.6 Million - $25.6 Million
-71,949 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$251.88 - $324.2 $11.5 Million - $14.8 Million
-45,696 Reduced 38.84%
71,949 $23.3 Million
Q3 2020

Nov 16, 2020

BUY
$255.22 - $317.0 $13.6 Million - $16.9 Million
53,327 Added 82.91%
117,645 $32.6 Million
Q2 2020

Aug 14, 2020

SELL
$141.4 - $257.09 $1.87 Million - $3.4 Million
-13,244 Reduced 17.08%
64,318 $15.5 Million
Q1 2020

May 15, 2020

BUY
$130.51 - $196.01 $4.68 Million - $7.03 Million
35,871 Added 86.04%
77,562 $11.3 Million
Q4 2019

Feb 14, 2020

SELL
$159.31 - $223.54 $4.42 Million - $6.2 Million
-27,741 Reduced 39.95%
41,691 $7.11 Million
Q3 2019

Nov 14, 2019

BUY
$175.89 - $279.23 $2.99 Million - $4.75 Million
17,003 Added 32.43%
69,432 $12.4 Million
Q2 2019

Aug 14, 2019

BUY
$250.96 - $284.94 $5.38 Million - $6.11 Million
21,428 Added 69.12%
52,429 $13.7 Million
Q1 2019

May 15, 2019

SELL
$276.39 - $362.25 $2.24 Million - $2.94 Million
-8,106 Reduced 20.73%
31,001 $8.85 Million
Q4 2018

Feb 14, 2019

SELL
$281.08 - $444.25 $5.2 Million - $8.22 Million
-18,506 Reduced 32.12%
39,107 $12.7 Million
Q3 2018

Nov 14, 2018

SELL
$354.53 - $449.75 $2.71 Million - $3.44 Million
-7,651 Reduced 11.72%
57,613 $25.9 Million
Q2 2018

Aug 14, 2018

BUY
$278.07 - $446.21 $6.41 Million - $10.3 Million
23,045 Added 54.58%
65,264 $26.7 Million
Q1 2018

May 15, 2018

BUY
$192.49 - $295.85 $3.48 Million - $5.34 Million
18,060 Added 74.75%
42,219 $12.3 Million
Q4 2017

Feb 14, 2018

BUY
$168.78 - $199.74 $4.08 Million - $4.83 Million
24,159
24,159 $4.53 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.